The AECOM/AECC Data Safety monitoring plan establishes implementation plans for the policies set forth by the National Cancer Institute in the document entitled """"""""Policy of the National Cancer Institute for Data and Safety Monitoring of Clinical Trials"""""""" ( These policies pertain to the monitoring of all clinical trials supported by NCI, and thus encompass all NCI funded clinical trials, intramural, multicenter and cooperative group. The policies and procedures for Data and Safety Monitoring of the clinical research programs at the AECC are established and monitored by the Protocol Review and Monitoring Committee and the Cancer Center Clinical Research Executive Committee. The Data Safety Monitoring Committee is a major component of the Cancer Center and reports directly to the head of the Protocol Review and Monitoring Committee, the CPDMU, the Cancer Center Director and the AECOM/Montefiore IRBs. The document includes the major functions and responsibilities of data and safety monitoring of our active clinical trials program(s) and includes a detailed description of the following: Individual responsible for monitoring The frequency of the review A description of what is being monitored The procedures for different classes of clinical trials The evaluation and investigator feedback/communication process The procedures for managing and averting conflicts of interest Adverse event procedures Suspensions of clinical trials Protocol compliance auditing procedures The Data Safety Monitoring Committee (DSMC) has the responsibility for ensuring data and safety monitoring along with each of the protocol Principal Investigators who are ultimately responsible for the ongoing monitoring and safety of clinical protocols. The DSMC is comprised of investigators from throughout the College and Cancer Center, and have a variety of different expertise. Dr. Richard Gorlick chairs the DSMC. The remainder of the membership is listed in the table below. The DSMC is provided with administrative support, database management, etc., by the CPDMU. The DSMC meeting occurs immediately prior to the PRMC meeting to ensure immediate transmission of information. Representatives of the CCI and PRMC serve in a non-voting capacity on the DSMC to assure communication.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
United States
Zip Code
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150
Yang, Chia-Ping Huang; Wang, Changwei; Ojima, Iwao et al. (2018) Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of ?-Tubulin and the Multidrug Resistance Associated P-Glycoprotein. J Nat Prod 81:600-606
Guan, Fangxia; Tabrizian, Tahmineh; Novaj, Ardijana et al. (2018) Dietary Walnuts Protect Against Obesity-Driven Intestinal Stem Cell Decline and Tumorigenesis. Front Nutr 5:37
Wang, Tao; Hosgood, H Dean; Lan, Qing et al. (2018) The Relationship Between Population Attributable Fraction and Heritability in Genetic Studies. Front Genet 9:352
Chennamadhavuni, Divya; Saavedra-Avila, Noemi Alejandra; Carreño, Leandro J et al. (2018) Dual Modifications of ?-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity. Cell Chem Biol 25:571-584.e8
Limi, Saima; Senecal, Adrien; Coleman, Robert et al. (2018) Transcriptional burst fraction and size dynamics during lens fiber cell differentiation and detailed insights into the denucleation process. J Biol Chem 293:13176-13190
Rocha, Agostinho G; Franco, Antonietta; Krezel, Andrzej M et al. (2018) MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science 360:336-341
Cabahug-Zuckerman, Pamela; Stout Jr, Randy F; Majeska, Robert J et al. (2018) Potential role for a specialized ?3 integrin-based structure on osteocyte processes in bone mechanosensation. J Orthop Res 36:642-652
Vilchèze, Catherine; Copeland, Jacqueline; Keiser, Tracy L et al. (2018) Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy. MBio 9:

Showing the most recent 10 out of 1508 publications